欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/2017/003
药品名称
Olmesartan medoxomilo + Amlodipina Macleods
活性成分
Amlodipine 10.0 mg
Olmesartan medoxomil 40.0 mg
剂型
Film-coated tablet
上市许可持有人
Macleods Pharma España, SLU
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Olmesartan medoxomil/Amlodipine Macleods 40 mg/10 mg Filmtabletten
Spain (ES)
Italy (IT)
许可日期
2021/07/14
最近更新日期
2024/10/10
药物ATC编码
C09DB02 olmesartan medoxomil and amlodipine
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
common_spc_clean_0012
Date of last change:2024/10/10
Final PL
|
common_pl_clean_0012
Date of last change:2024/10/10
Final Product Information
|
common_impack
Date of last change:2024/09/06
Final Product Information
|
common_outer
Date of last change:2024/09/06
Final Product Information
|
common_pl
Date of last change:2024/09/06
Final Product Information
|
common_spc
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase